AbbVie turns to newer immunology drugs as blockbuster Humira faces lower-cost competition By: MarketWatch July 25, 2023 at 10:41 AM EDT Investors look for signs that Skyrizi, Rinvoq can take the baton as Humira sales falter Read More >> Related Stocks: AbbVie Coherus Bio
